Compare, Analyse Orchid Pharma with ACTAVIS INC. - US - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ORCHID PHARMA vs ACTAVIS (US) - Comparison Results

ORCHID PHARMA     Change

Orchid Chemicals & Pharmaceuticals Ltd. (Orchid) is today a globally recognized, integrated pharmaceutical company with core competencies in the development and manufacture of Active Pharmaceutical Ingredients (APIs) and Finished Dosage Forms as well... More

ACTAVIS (US)
   Change

Actavis, Inc. is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. It develops, manufactures and market generic, branded generic, legacy brands and Over... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 ORCHID PHARMA   ACTAVIS
EQUITY SHARE DATA
    ORCHID PHARMA
Sep-13
ACTAVIS
Dec-18
ORCHID PHARMA/
ACTAVIS
5-Yr Chart
Click to enlarge
High Rs19413,998-   
Low Rs359,390-   
Sales per share (Unadj.) Rs276.53,433.6-  
Earnings per share (Unadj.) Rs-79.2-1,106.0-  
Cash flow per share (Unadj.) Rs-43.5361.8-  
Dividends per share (Unadj.) Rs00-  
Dividend yield (eoy) %00-  
Book value per share (Unadj.) Rs53.914,162.2-  
Shares outstanding (eoy) m70.45332.60-   
Bonus/Rights/Conversions ESOP--  
Price / Sales ratio x0.43.4 12.2%   
Avg P/E ratio x-1.4-10.6 13.7%  
P/CF ratio (eoy) x-2.632.3 -8.2%  
Price / Book Value ratio x2.10.8 257.1%  
Dividend payout %00-   
Avg Mkt Cap Rs m8,0673,889,345 0.2%   
No. of employees `0002.816.9 16.6%   
Total wages/salary Rs m2,5270-   
Avg. sales/employee Rs Th6,956.167,575.8 10.3%   
Avg. wages/employee Rs Th902.50-   
Avg. net profit/employee Rs Th-1,993.0-21,766.2 9.2%   
INCOME DATA
Net Sales Rs m19,4771,142,032 1.7%  
Other income Rs m40721,839 1.9%   
Total revenues Rs m19,8841,163,871 1.7%   
Gross profit Rs m1,10329,927 3.7%  
Depreciation Rs m2,519488,194 0.5%   
Interest Rs m5,22765,902 7.9%   
Profit before tax Rs m-6,236-502,329 1.2%   
Minority Interest Rs m200-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m511128,114 0.4%   
Tax Rs m-125-6,366 2.0%   
Profit after tax Rs m-5,580-367,849 1.5%  
Gross profit margin %5.72.6 216.0%  
Effective tax rate %2.01.3 158.4%   
Net profit margin %-28.7-32.2 88.9%  
BALANCE SHEET DATA
Current assets Rs m11,014468,402 2.4%   
Current liabilities Rs m32,060414,364 7.7%   
Net working cap to sales %-108.14.7 -2,283.6%  
Current ratio x0.31.1 30.4%  
Inventory Days Days9520 484.5%  
Debtors Days Days3466 50.6%  
Net fixed assets Rs m29,440129,272 22.8%   
Share capital Rs m7050-   
"Free" reserves Rs m2,0430-   
Net worth Rs m3,8004,710,347 0.1%   
Long term debt Rs m9,0181,658,684 0.5%   
Total assets Rs m46,5107,363,344 0.6%  
Interest coverage x-0.2-6.6 2.9%   
Debt to equity ratio x2.40.4 673.9%  
Sales to assets ratio x0.40.2 270.0%   
Return on assets %-0.8-4.1 18.5%  
Return on equity %-146.9-7.8 1,880.5%  
Return on capital %-3.7-4.8 77.1%  
Exports to sales %37.90-   
Imports to sales %22.60-   
Net fx Rs m1,8650-   
CASH FLOW
From Operations Rs m1,682408,005 0.4%  
From Investments Rs m-9,860224,145 -4.4%  
From Financial Activity Rs m6,644-700,258 -0.9%  
Net Cashflow Rs m-1,535-67,768 2.3%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ACTAVIS (US) is United States Dollars. All data has been converted at 72.34 Rs / USD

Compare ORCHID PHARMA With: MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  

Compare ORCHID PHARMA With: SUN PHARMA  NEULAND LABS  SANOFI INDIA  PFIZER  GSK PHARMA  



Today's Market

Sensex Zooms 1,030 Points, Nifty Tops 14,980-Mark; HDFC Bank Among Top Gainers(Closing)

Indian share markets witnessed huge buying interest during the extended closing hours today and ended their day on a strong note.

Related Views On News

Most Popular

Intraday Trading for a Living (Fast Profits Daily)

Feb 15, 2021

In this video, I'll cover your queries on intraday trading and also share my view on how to decide stop losses and target prices.

Penny Stock Master Series: The Quest for 10X Profits in 10 Years (Profit Hunter)

Feb 12, 2021

This is first of the three part master series. In these editorials, I'll show you how to earn 10X returns from a penny stock portfolio over 10 years.

Top 5 Stocks Mutual Funds Bought and Sold in January 2021 (Sector Info)

Feb 16, 2021

A look at what India's top equity mutual funds bought and sold in January 2021.

I Would Recommend this Small-cap Stock Over Tesla (Profit Hunter)

Feb 16, 2021

Do you enjoy reading Tesla and Bitcoin stories? Here's a not so famous small-cap stock to profit from the rise of EVs.

More
-->

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

OUR TOP 5 IDEAS

Access Now: Eight Steps to Your Eight Figure Fortune
Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
Covid-19 Proof Multibagger Stocks - Download this FREE Report Now
Free Report: The Secret to Increasing Your Trading Profits Daily!
No Guessing, No Hunches, and No Missed Trends Ever! Join Us on YouTube Now.

ORCHID PHARMA SHARE PRICE


Feb 24, 2021 (Close)

TRACK ORCHID PHARMA

  • Track your investment in ORCHID PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ORCHID PHARMA

ORCHID PHARMA 8-QTR ANALYSIS

COMPARE ORCHID PHARMA WITH

FEATURED VIDEOS

How Long Before a Big Stock Market Crash

I Believe the Investment of the Year Will Be...

Nasdaq & Nifty Could Reverse

Don't Fall for the 'Best Sector of 2021' Story

More Featured Videos

MARKET STATS